Posted: March 20th, 2012 | Author: Michael Courtenay | Filed under: Medical Research, Science, Science News | Tags: Chronic Obesity, Genetics, Obesity, Science News ©indeep media: http://www.cankler.com.au/ | Comments Off
The discovery offers clues about how to turn on brain sensitivity to leptin and insulin, hormones that turn off appetite.
Researchers at Georgetown University Medical Center have revealed how a mutation in a single gene is responsible for the inability of neurons to effectively pass along appetite suppressing signals from the body to the right place in the brain. What results is obesity caused by a voracious appetite.
Their study, published March 18th on Nature Medicine‘s website, suggests there might be a way to stimulate expression of that gene to treat obesity caused by uncontrolled eating.
The research team specifically found that a mutation in the brain-derived neurotrophic factor (Bdnf) gene in mice does not allow brain neurons to effectively pass leptin and insulin chemical signals through the brain. In humans, these hormones, which are released in the body after a person eats, are designed to “tell” the body to stop eating. But if the signals fail to reach correct locations in the hypothalamus, the area in the brain that signals satiety, eating continues. Read the full article »»»»
Posted: March 14th, 2012 | Author: Michael Courtenay | Filed under: Medical Research, Science, Science News | Tags: Anthropogenic Global Warming Obsessive Compulsive Disorder, Climate Change, Global Warming, Obsessive Compulsive Disorder, OCD | Comments Off
A new published study has highlighted how the media influences opinion on emotive issues. The study undertaken by the University of Sydney was carried out to investigate whether climate change had any impact on the nature of the obsessions or compulsions experienced by sufferers of Obsessive Compulsive Disorder – OCD – The study takes reference from a 1994 study which found that some children developed obsessive thoughts about Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome – HIV/Aids – once media reports on the virus became common place.
“We suggest that mental health professionals need to be aware of, and assess for the presence of such concerns” the study recommended.
This latest study has found that many patients suffering with OCD are worrying about the effects of climate change and global warming. Dr Mairwen Jones and her co-authors looked at 50 patients attending an anxiety disorders clinic. They found one-third of the patients had anxiety about the effects of climate change. The most common concerns were wasting water, gas and electricity, often leading to an obsessive checking to make sure utilities and appliances were switched off. Read the full article »»»»
Posted: February 25th, 2012 | Author: Michael Courtenay | Filed under: Science, Science News | Tags: Albert Einstein, CERN, European Organization for Nuclear Research, Fermilab, Gran Sasso Laboratory, Indiana University Professor Alan Kostelecky, Italian National Institute of Nuclear Physics, James Gillies Head of Communication, Jenny Thomas, neutrinos, OPERA, sub-atomic particles, Theory of Relativity, University College of Londo | Comments Off
The controversial finding that cast a large shadow of doubt over Einstein’s belief that nothing can travel faster than the speed of light might have been caused by a loose cable, the lab behind the result said. Physicists at the CERN laboratory near Geneva appeared to contradict Albert Einstein last year when they reported that sub-atomic particles called neutrinos could travel fractions of a second faster than light. Einstein had said nothing could travel faster than light.
James Gillies, a spokesman for CERN, said the lab’s startling result was now in doubt. Earlier on Wednesday, the website ScienceInsider reported the surprising result was down to a loose fibre optic cable linking a Global Positioning System satellite receiver to a computer. ScienceInsider is run by the respected American Association for the Advancement of Science. Mr Gillies confirmed a flaw in the GPS system was now suspected as a possible cause for the surprising reading. Gillies’ says further testing was needed before any definite conclusions could be reached. Read the full article »»»»
Posted: January 17th, 2012 | Author: Michael Courtenay | Filed under: Medical Research, Science, Science News | Tags: Alcohol, Alcoholism, DHM, Dihydromyricetin, Dr Jing Liang, Hovenia Dulcas, medicine, Rehab, Treatment, UCLA, University of California, World Health Organization | Comments Off
Researchers at the University of California – UCLA – are investigating a 500-year-old Chinese hangover cure in the hope they can put its properties into a pill to help alcoholics and stave off hangovers. Alcoholism is a huge problem globally, killing 2.5 million people each year according to the World Health Organization. There has been serious research recently looking for drugs that stop people drinking, or at least encourage them to drink less.
In an article published in the latest issue of the Journal of Neuroscience, they describe how dihydromyricetin blocks the action of alcohol on the brain and neurons and also reduces voluntary alcohol consumption, with no major side effects, in an early study with rats. Only an estimated 13 percent of people identified as having an alcohol use disorder receive medical treatment, partly due to a lack of effective medications without major side effects. Read the full article »»»»
Posted: December 20th, 2011 | Author: Michael Courtenay | Filed under: Science, Science News, Socially Engineerd | Tags: 5-IN-5, Analytics, Bruce Powel Douglass, Energy, Five-In-Five, Future Predictions, IBM, Mind Reading, Mobile, Security | 1 Comment »
Century-old technology behemoth IBM has done some pretty wild things in it’s time. They’ve dragged us from Keypunch through Typesetting and on to Supercomputing technology. So when the behemoth makes a prediction, the world listens, even when it’s outlandish. IBM has predicted a near future in which machines read minds and recognise who they are dealing with. Each year since 2006, IBM has released Five-In-Five, a list of 5 predictions for the future of tech, 5 innovations that will have a profound effect in the next 5 years. The latest IBM Five-in-Five predictions were based on social trends and research which the New York State-based company expected to begin bearing fruit by the year 2017. You might want to start practicing being nice to machines, IBM says “Imagine you will be able to walk up to an ATM machine to securely withdraw money by simply speaking your name or looking into a tiny sensor that can recognise the unique patterns in the retina of your eye”
Posted: December 7th, 2011 | Author: Michael Courtenay | Filed under: Medical Research, Science, Science News | Tags: Alzheimer's and Parkinson's Disease Laboratory, Alzheimer's Disease, Alzheimer's Vaccine, Associate Professor Lars Ittner, Cankler Science News, MAPT, Microtubule Associated Protein Tau, Science News, Sydney University, Tau Proteins | Comments Off
Researchers have had success with a vaccine that could ultimately slow down advanced Alzheimer’s disease in humans. The team from Sydney University have published – PLoS ONE – details of a study which shows the vaccine slows one type of dementia by stopping neuro-fibre tangling. Associate Professor Lars Ittner from Sydney University – Alzheimer’s and Parkinson’s Disease Laboratory says the study was conducted on mice that were already developing the condition. Ittner said it was the first time researchers had proved a vaccine that targeted the tau protien in mice that had already developed the disease. Ittner says that their approach was different, until now most research has targeted the tau protiens in younger animals, prior to the onset of Alzheimer’s disease. ”What we attempted to do was to work with older mice with a lot of damage. Because in people, by the time they realise their symptoms are Alzheimer’s disease, a lot of damage has already been done.” said Ittner. The researchers say their novel approach worked, producing some of the most improved results so far recorded in mice with advanced dementia. READ MORE